Oakdale, MN, United States of America

Debra Mullins-Hirte

This inventor holds 1 USPTO granted patent. Top assignee: Arteriocyte Medical Systems, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Debra Mullins-Hirte. Retrieved from https://idiyas.com/inventor/debra-mullins-hirte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debra Mullins-Hirte: Innovator in Biological Compositions

Introduction

Debra Mullins-Hirte is a notable inventor based in Oakdale, MN (US). She has made significant contributions to the field of biological compositions, showcasing her expertise and innovative spirit.

Latest Patents

Debra holds 1 patent for her invention titled "Compositions and methods of preparation thereof." This patent provides biological compositions and methods for making the same, reflecting her commitment to advancing medical science.

Career Highlights

Debra is currently employed at Arteriocyte Medical Systems, Inc., where she continues to develop her innovative ideas. Her work at this company highlights her dedication to improving healthcare through scientific advancements.

Collaborations

Some of her coworkers include Kenneth E Merte and Laura A Yonce, who contribute to the collaborative environment that fosters innovation at Arteriocyte Medical Systems, Inc.

Conclusion

Debra Mullins-Hirte is a pioneering inventor whose work in biological compositions is making a difference in the medical field. Her contributions and collaborations reflect her commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…